Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
The Novel CXCR4 Antagonist KRH-3955 Is an Orally Bioavailable and Extremely Potent Inhibitor of Human Immunodeficiency Virus Type 1 Infection: Comparative Studies with AMD3100
Antimicrobial Agents and Chemotherapy, 07/01/09
Murakami T et al. - The compound shows an oral bioavailability of 25.6% in rats, and its oral administration blocks X4 HIV-1 replication in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse system. Thus, KRH-3955 is a new promising agent for HIV-1 infection and AIDS.
Related Articles
Listener Preferences and Trainable Hearing Aids: Historical Perspectives, Current Trends and Practical Considerations
The Hearing Journal, 10/19/09
Relevance Score: 90%
AIDS-Living with AIDS
MedLinePlus, 10/09/09
Relevance Score: 90%
Size Matters When It Comes to AIDS Defense
MedLinePlus, 11/02/09
Relevance Score: 89%
Size matters when it comes to AIDS defense
Reuters, 10/29/09
Relevance Score: 89%
Rate of HIV/AIDS positives still increases 1,436 people tested positive for HIV in 5 months
Internet Source, 11/11/09
Relevance Score: 88%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Selection and counterselection of the adefovir resistance mutation rtI233V during antiviral therapy
Journal of Clinical Microbiology, 12/18/09
The regulatory role of the MisR/S two-component system in hemoglobin utilization in Neisseria meningitidis
Infection and Immunity, 12/18/09
The Interleukin 6 -174 C/C Genotype Predicts Greater Rhinovirus Illness
The Journal of Infectious Diseases, 12/18/09
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-Term Complete Regression of Nodal Marginal Zone Lymphoma Transformed Into Diffuse Large B-Cell Lymphoma With Highly Active Antiretroviral Therapy Alone in Human Immunodeficiency Virus Infection
The American Journal of the Medical Sciences, 12/18/09
Temporal Reduction of HIV Type 1 Viral Load in Breast Milk by Single-Dose Nevirapine during Prevention of MTCT
AIDS Research and Human Retroviruses, 12/18/09
Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage
Journal of Clinical Virology, 12/18/09
Article Search
Sponsor


See Latest Articles


